Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report.
Intrahepatic cholangiocarcinoma account for 13% of annual cancer-related deaths worldwide and for 3% in the USA. Patient with unresectable disease can benefit from palliative therapies such as systemic chemotherapy. However, the only curative treatment for intrahepatic cholangiocarcinoma is complete surgical resection with histologically negative resection margins.
Poggi
Guido
G
Department of Oncology, Fondazione S. Maugeri, Istituto Scientifico di Pavia, Italy. guido.poggi@fsm.it
Quaretti
Pietro
P
Minoia
Claudio
C
Palumbo
Ilaria
I
Villani
Laura
L
Amatu
Alessio
A
Teragni
Cristina
C
Scelsi
Mario
M
Zappoli
Federico
F
Bernardo
Giovanni
G
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001650:Bile Duct Neoplasms / Q000098:blood supply / Q000628:therapy*; D001653:Bile Ducts, Intrahepatic / Q000098:blood supply / Q000473:pathology*; D016461:Chemoembolization, Therapeutic / Q000379:methods*; D018281:Cholangiocarcinoma / Q000098:blood supply / Q000628:therapy*; D005260:Female; D006801:Humans; D008863:Microspheres; D009944:Organoplatinum Compounds / Q000008:administration & dosage*; D000077150:Oxaliplatin
D000970:Antineoplastic Agents; D009944:Organoplatinum Compounds; D000077150:Oxaliplatin